| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.80B | 83.10B | 79.43B | 72.98B | 70.93B | 73.89B |
| Gross Profit | 24.13B | 23.73B | 19.79B | 12.97B | 17.39B | 21.90B |
| EBITDA | 12.29B | 12.16B | 9.37B | 4.30B | 8.99B | 12.99B |
| Net Income | 5.20B | 4.44B | 3.52B | -2.04B | 2.53B | 4.04B |
Balance Sheet | ||||||
| Total Assets | 109.49B | 107.62B | 103.50B | 104.90B | 104.93B | 100.24B |
| Cash, Cash Equivalents and Short-Term Investments | 24.03B | 23.34B | 14.92B | 16.03B | 12.48B | 13.89B |
| Total Debt | 31.99B | 33.07B | 32.28B | 39.70B | 36.91B | 32.03B |
| Total Liabilities | 51.80B | 50.81B | 48.68B | 53.94B | 50.42B | 46.09B |
| Stockholders Equity | 57.69B | 56.81B | 54.82B | 50.95B | 54.51B | 54.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.57B | 6.16B | 3.10B | -4.54B | 6.48B |
| Operating Cash Flow | 0.00 | 12.22B | 8.38B | 4.67B | 5.85B | 10.47B |
| Investing Cash Flow | 0.00 | -9.01B | 1.05B | -4.15B | -11.61B | -4.33B |
| Financing Cash Flow | 0.00 | -1.72B | -8.79B | 888.00M | 3.01B | -4.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥60.85B | 4.62 | ― | 2.44% | 5.74% | 76.28% | |
76 Outperform | ¥222.17B | 9.63 | 7.56% | 2.84% | 2.63% | -7.81% | |
69 Neutral | ¥68.37B | 13.32 | ― | 3.98% | 1.21% | -14.59% | |
65 Neutral | ¥35.39B | 14.63 | ― | 0.72% | -2.02% | 103.08% | |
63 Neutral | ¥63.56B | 22.47 | ― | 0.34% | 4.70% | -2.58% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
53 Neutral | ¥97.53B | 7.70 | ― | 3.59% | 4.55% | 79.33% |